HomeAsthma

  • NICE publishes new COVID-19 guidelines on patients with asthma and other conditions

    • April 6, 2020
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Dupixent® (Dupilumab) approved by FDA for Asthma indication

    • October 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Spiriva Respimat gets UK license for young asthma patients

    • June 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • AstraZeneca’s Fasenra Fails in Phase III COPD Trial

    • May 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Verona Pharma to Present Clinical Trial Data of RPL554 at ATS (American Thoracic Society 2018) Conference

    • May 9, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Verona Pharma to Mark its Presence at BioEquity Europe 2018

    • May 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD

    • April 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Novartis updates Launch Timeline for Advair Copy to 2019

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more